This article has Open Peer Review reports available.
Temporal histological changes in lacrimal and major salivary glands in mouse models of Sjogren’s syndrome
© Xuan et al.; licensee BioMed Central Ltd. 2013
Received: 29 April 2013
Accepted: 26 September 2013
Published: 5 October 2013
Evidence in imaging studies suggests that there may be differences in glandular involvement in Sjogren’s syndrome (SS) depending on the stage of the disease. No detailed histological studies are available to show if there are any such difference in glandular involvement at various time periods and stages of SS. This cross sectional study examines the inflammatory changes in mouse models of SS at various ages.
The histological changes in major salivary and lacrimal glands were studied at ages of 3, 6, 9, 12, 15 and 18 months in both sexes in well characterized mouse models of SS, non-obese diabetes mouse and Interleukin-14 alpha-transgenic mice.
Our results indicate that early inflammation concurrently occur in submandibular and lacrimal glands around the age of 6 weeks. Parotid glands are involved much later in the course of SS with less severe inflammation. Sublingual glands are rarely involved.
Our conclusions are that SS may be an organ specific disease with early inflammation occurring in submandibular and lacrimal glands, followed by the parotid. Non organ specific events occur in later courses of the disease. The understanding of the disease progression is important in tailoring early local therapeutic interventions before complete destruction of salivary and lacrimal glands.
Sjogren’s syndrome (SS) is an autoimmune mediated disorder characterized by inflammation and dysfunction of salivary and lacrimal glands resulting in dryness of the mouth and eyes . The etiology and pathogenesis of SS is not well understood. The diagnosis of SS is complex and based on multiple criteria encompassing serology, histopathology, and imaging . The histological hall mark of SS is foci of periductal and perivascular inflammation of lymphocytes mainly in the salivary and lacrimal glands. The inflammatory infiltrate leads to complete destruction of acini with loss of secretory function of the glands and eventually development of B-cell lymphomas [2, 3]. All of the diagnostic criteria, in addition to the recently revised American College of Rheumatology classification recommends use of labial minor salivary gland (MSG) biopsy exhibiting focal lymphocytic infiltrate for diagnosis of SS [4, 5].
The clinical changes of dry mouth and dry eyes are predominantly due to destruction of major salivary glands and lacrimal glands. There is evidence in the imaging studies using scintigraphy, magnetic resonance imaging and ultrasonography showing that salivary and lacrimal glands display changes associated with SS. The imaging studies also show that there may be differences in the progression of disease in the different exocrine salivary and lacrimal glands. The submandibular glands show the most diagnostic alterations regarding salivary flow rates in SS causing the dry mouth, followed by parotid [6–8]. The sublingual glands are less severely involved in SS than the other major salivary glands . Imaging and histological studies of lacrimal gland are minimal and available results show that there may be progressive dysfunction of the gland .
Although there have been evidence in imaging studies showing the salivary gland changes in SS depending on the stage of the disease, there have been no cross-sectional and temporal histological studies available. The reasons are that it is difficult to study the longitudinal changes occurring in the major salivary glands and the lacrimal glands in humans due to the inability to obtain serial biopsies. The mouse models of SS provide the ideal opportunity for histological studies because of several advantages. The mouse models replicates the disease course in humans, clinical features and complications of SS and gives researchers insights into the disease pathogenesis. Other salient features of mouse models that are of advantage in the study of the SS are the short lifespan of a mouse allowing to study changes occurring from birth to death, uniform genetic backgrounds, and relative ease in breeding of the models [11, 12].
The aim of the study is to describe the histological changes occurring at various ages (temporal) in the major salivary glands (submandibular, parotid and sublingual) and lacrimal glands of the mouse models. We selected non-obese diabetes (NOD) mouse, the most popular and extensively studied mouse model of SS [13, 14] and interleukin-14 alpha-transgenic (IL-14α-TG) mice, the mouse model for primary SS [15, 16]. A control group was also included in the study.
NOD mice and C57/BL6 (control) mice were obtained from the Jackson Laboratory (Bar Harbor, ME) and housed in the Laboratory Animal Facility at the State University of New York at Buffalo. IL14-α-TG mice were made by Dr. Ambrus’ laboratory and maintained in the Laboratory Animal Facility at SUNY Buffalo . Animal studies were approved by institutional animal care and use committee at the State University of New York at Buffalo. All procedures were conducted in compliance with the institutional guidelines on use of animals in research.
A total of 108 mice were included in the study, 2 male and 4 female mice for each group (C57/BL6 controls, IL-14α TG and NOD) were sacrificed at time points ranging from 3 to 18 months (6 time points of 3, 6, 9, 12, 15 & 18 months). The major salivary (parotid, submandibular, & sublingual) and lacrimal gland were removed, bilaterally, and placed in 10% formalin and tissue processed for hematoxylin and eosin staining (H & E) for evaluation using standard processing techniques. Three 5 μm thick embedded paraffin sections separated by 50 μm were used for the analysis. The sections were reviewed and scored blindly by a pathologist using the classification criteria described below.
Statistical method: the data were analyzed by Chi-Square test, χ2 > χ2 (1, 0.05). The P value <0.05 was considered statistically significant. When the sample size was less than 40, Fisher exact probabilities were utilized.
IL-14α- TG and the NOD mouse showed similar inflammation patterns, in the type of glands affected, the severity and the time point at which it occurred (Figure 2). The mild inflammation of the submandibular and lacrimal glands of the IL-14α-TG and the NOD mouse begins at 6 months of the age. The inflammation becomes moderate at 15 months of age and severe at 18 months of age, when 6 out of 6 mice demonstrated some level of inflammation.
The parotid glands involvement is widespread by 15 and 18 months and relatively less severe compared to the lacrimal or submandibular glands. The sublingual gland involvement is minimal, appears later at 18 months, and the inflammation is less severe.
The NOD mouse is one of the popular mouse models for the study of SS. In addition to having diabetes shows features of SS similar to human such as dry mouth, dry eyes, presence of autoantibodies (Ro, La), lymphocytic infiltration of salivary, lacrimal glands and hypergammaglobulinemia . The chronological and histological changes occurring in submandibular gland has been well studied in the NOD mice. The initial changes start appearing at approximately 8 weeks-old . All of the NOD mouse sub mandibular glands are affected by age 18 months [11, 14, 19]. However, no chronological studies on inflammation of parotid, sublingual or lacrimal glands for the NOD mouse or any other mouse model are available.
The Interleukin-14 alpha-transgenic mouse model could be an ideal mouse model to study primary SS. Interleukin-14  increases germinal B-cell proliferation, including B1 and B2 activated cells . The IL-14α-TG reproduces the features of primary SS as seen in patients in the same relative time frame as humans, including autoantibodies, early destruction and infiltration of the salivary and lacrimal glands with lymphocytes, and eventually lymphoma [15, 16, 21]. The mouse also develops inflammation of other organs such as kidney and lungs by 15 months of age [15, 16].
The major salivary glands, parotid, submandibular and sublingual glands contribute to over 90 percent of the saliva secreted [22, 23]. The minor salivary glands scattered throughout oral mucosa contribute to rest of the 7–10 percent of saliva [24, 25]. Parotid gland secretions are purely serous in nature and contribute to the majority of stimulated saliva . The submandibular saliva is mixed in nature containing mucus and serous secretions. The unstimulated saliva is mainly produced from submandibular gland . The sublingual saliva is predominantly mucus and its contribution to unstimulated and stimulated whole saliva is limited. The most diagnostic alterations in SS regarding salivary flow rates occur in submandibular gland followed by the parotid [7, 27]. The results of our studies show that in addition to salivary flow changes, early inflammatory infiltration is seen the submandibular glands of both NOD and IL-14α-TG mouse. The inflammatory change occurs as early as 6 weeks of age and is most severe during the 16 weeks of age. The parotid glands inflammatory changes occur later at 12 weeks of age. The sublingual glands are rarely involved in the both mouse models (Figure 2).
The lacrimal gland changes of lymphocytic infiltration in our study occurs approximately at 6 weeks of age onwards and occur in tandem with submandibular gland inflammation (Figure 2). The changes appear in both the NOD and IL-14α-TG mouse models. Earlier studies of lacrimal glands of NOD mouse have shown that the inflammation occur between 6–8 weeks of age . There are gender-related differences in the degree of exocrine gland inflammation that have also been reported in NOD mice . This difference in severity of inflammation in the lacrimal glands of the NOD mouse may be attributed to hormonal influences of insulin. The deficiency of insulin in NOD mouse causes decrease in activity and survival of lacrimal gland acini .
In one of the few comparative histological studies available comparing between lacrimal and submandibular glands, in the NOD mouse model, the inflammation was found to be higher in the lacrimal, as compared to submandibular glands . Interestingly there was difference in inflammation between the male and female mouse. The inflammation was worse in lacrimal glands of males than females . Studies also show that inflammation began at around 6–8 weeks of age. By the 12th week approximately 25% of the lacrimal gland was infiltrated with lymphocytic inflammation. There is evidence that androgens may play a role in inflammation. The orchiectomy of NOD mice decreased lymphocytic inflammation due to lack of androgens . There was no significant difference between the male and female mouse in our study.
Although major salivary and lacrimal glands show saliva or tear flow and inflammatory changes in early SS, there have been only a few studies showing their utility in diagnosis. The studies using parotid [33, 34] or sublingual gland [35, 36] biopsies have shown that they may provide better specificity and sensitivity for diagnosis of SS than the commonly used minor salivary gland biopsies . To our knowledge, no studies of submandibular or lacrimal gland biopsies for diagnosis of SS have been reported in the literature. The reasons that there is a lack of major salivary or lacrimal gland biopsies may be due to the invasive nature of the surgical procedure and requirement of general anesthesia in comparison to minor gland biopsies. In addition, complications such as altered sensation in the pre-auricular area, sialocele, facial nerve damage, salivary fistula and swelling in the floor of the mouth may also occur in the major salivary gland biopsies .
Recent evidence suggests that the early disease of SS in the mouse models and the humans may be organ specific. In both patients and animal models there the injury to the salivary glands occurs prior to and independent of parenchymal lymphocytic infiltration . The injury is followed by local production of soluble lymphotoxins in the salivary or lacrimal glands of IL-14α-TG mice that is necessary for the development of overt SS . In addition, the antibodies to salivary protein 1 localized to major salivary glands and lacrimal glands, are produced early in the disease, before the production of antibodies to Ro La, and/or lymphocytic infiltration of the minor salivary glands .
In conclusion, our findings indicate that the early inflammation in male or female mice concurrently occurs in the submandibular and lacrimal glands at around the age of 6 weeks. The parotid glands are involved much later in the course of SS with less severe inflammation. The sublingual glands are rarely involved. Based on our mouse model studies, early SS begins as an organ specific disease in the submandibular and lacrimal glands and progresses to the other salivary glands. Later during the course of the disease other organ systems are affected and development of lymphoma. Based on these findings, we hypothesize that human SS may mimic the mouse model and identification of organ specific antibodies, in the major salivary and lacrimal glands may lead to early diagnosis and thereby treatment of SS.
We like to acknowledge Chris Becker, Histotechnologist at IMMCO Diagnostics, for preparation of the slides.
IMMCO provided the funding to LS and KM for raw materials and time required for processing of the slides.
Troup fund of Kaleida Health Foundation support to JA for the maintenance of mouse colonies for the study.
- Mavragani CP, Moutsopoulos HM: The geoepidemiology of Sjogren’s syndrome. Autoimmun Rev. 2010, 9: A305e10-View ArticleGoogle Scholar
- Christodoulou MI, Kapsogeorgou EK, Moutsopoulos HM: Characteristics of minor salivary gland infiltrates in Sjogren’s syndrome. J Autoimmun. 2010, 34: 400-407. 10.1016/j.jaut.2009.10.004.View ArticlePubMedGoogle Scholar
- Voulgarelis M, Moutsopoulos HM: Mucosa –associated lymphoid tissue lymphoma in Sjogren’s syndrome: risks, management and prognosis. Rheum Dis Clin North Am. 2002, 34: 921-933.View ArticleGoogle Scholar
- Shiboski SC, Shiboski CH, Criswell L, et al: American college of rheumatology classification criteria for Sjögren's syndrome: a data-driven, expert consensus approach in the Sjögren’s international collaborative clinical alliance cohort. Arthritis Care Res. 2012, 64: 475-487. 10.1002/acr.21591.View ArticleGoogle Scholar
- Vitali C, Bombardieri S, Jonsson R, et al: Classification criteria for Sjogren’s syndrome: a revised version of the European criteria proposed by the American-European consensus group. Ann Rheum Dis. 2002, 61: 554-558. 10.1136/ard.61.6.554.View ArticlePubMedPubMed CentralGoogle Scholar
- Aung W, Murata Y, Ishida R, Takashi Y, Okada N, Sibuya H: Study of quantitative oral radioactivity in salivary gland scintigraphy and determination of the clinical stage of Sjögren’s syndrome. J Nucl Med. 2001, 42: 38-43.PubMedGoogle Scholar
- Pijpe J, Kalk WWI, Bootsma H, Spijkervet FKL, Kallenberg CGM, Vissink A: Progression of salivary gland dysfunction in patients with Sjögren’s syndrome. Ann Rheum Dis. 2007, 66: 107-112.View ArticlePubMedGoogle Scholar
- Wernicke D, Hess H, Gromnica-Ihle E, Krause A, Schmidt WA: Ultrasonography of salivary glands – a highly specific imaging procedure for diagnosis of Sjögren’s syndrome. J Rheumatol. 2008, 35: 285-293.PubMedGoogle Scholar
- Sumi M, Izumi M, Yonetsu K, Nakamura T: Sublingual gland: MR features of normal and diseased states. AJR Am J Roentgenol. 1999, 172: 717-722. 10.2214/ajr.172.3.10063867.View ArticlePubMedGoogle Scholar
- Izumi M, Eguchi K, Uetani M, et al: MR features of the lacrimal gland in Sjögren’s syndrome. AJR Am J Roentgenol. 1998, 170: 1661-1666. 10.2214/ajr.170.6.9609194.View ArticlePubMedGoogle Scholar
- Jonsson MV, Delaleu N, Jonsson R: Animal models of Sjogren’s syndrome. Clinic Rev Allerg Immunol. 2007, 32: 215-224. 10.1007/s12016-007-8012-7.View ArticleGoogle Scholar
- Soyfoo MS, Steinfeld S, Delporte C: Usefulness of mouse models to study pathogenesis of Sjogren’s syndrome. Oral Dis. 2007, 13: 366-375. 10.1111/j.1601-0825.2007.01376.x.View ArticlePubMedGoogle Scholar
- Cha S, Peck AB, Humphreys-Beher MG: Progress in understanding autoimmune exocrinopathy using non obese diabetic mouse: an update. Crit Rev Oral Biol Med. 2002, 13: 4-16. 10.1177/154411130201300102.View ArticleGoogle Scholar
- Jonsson MV, Delaleu N, Brokstad KA, Berggreen E, Skarstein K: Impaired salivary function in NOD mice. Arthritis Rheum. 2006, 54: 2300-2305. 10.1002/art.21945.View ArticlePubMedGoogle Scholar
- Shen L, Suresh L, Wu J, et al: A role for lymphotoxin in primary Sjogren’s disease. J Immunol. 2010, 185: 6355-6363. 10.4049/jimmunol.1001520.View ArticlePubMedGoogle Scholar
- Shen L, Suresh L, Li H, et al: IL-14alpha, the nexus for primary Sjogren’s disease in mice and humans. Clin Immunol. 2009, 130: 304-312. 10.1016/j.clim.2008.10.006.View ArticlePubMedGoogle Scholar
- Shen L, Zhang C, Wang T, et al: Development of autoimmunity in interleukin-14alpha transgenic mice. J Immunol. 2006, 177: 5676-5686.View ArticlePubMedGoogle Scholar
- Greenspan JS, Daniels TE, Talal N, Sylvester RA: The histopathology of Sjogren’s syndrome in labial salivary gland biopsies. Oral Surg Oral Med Oral Pathol. 1974, 37: 217-229. 10.1016/0030-4220(74)90417-4.View ArticlePubMedGoogle Scholar
- Roescher N, Lodde BM, Vosters JL, Tak PP, Catalan MA, Illei G, Chiorini JA: Temporal changes in salivary glands of non-obese mice as a model for Sjogren’s syndrome. Oral Dis. 2012, 18: 96-106. 10.1111/j.1601-0825.2011.01852.x.View ArticlePubMedGoogle Scholar
- Ambrus J, Pippin J, Joseph A, et al: Identification of a cDNA for a human high molecular weight B cell growth factor (interleukin 14). Proc Natl Acad Sci U S A. 1993, 90: 6330-6334. 10.1073/pnas.90.13.6330.View ArticlePubMedPubMed CentralGoogle Scholar
- Shen L, Suresh L, Lindemann M, et al: Novel autoantibodies in Sjogren’s syndrome. Clin Immunol. 2012, 145: 251-255. 10.1016/j.clim.2012.09.013.View ArticlePubMedGoogle Scholar
- Mese H, Matsuo R: Salivary secretion, taste and hyposalivation. J Oral Rehabil. 2007, 34: 711-723. 10.1111/j.1365-2842.2007.01794.x.View ArticlePubMedGoogle Scholar
- Navazesh M: Methods for collecting saliva. Ann N Y Acad Sci. 1993, 694: 72-77. 10.1111/j.1749-6632.1993.tb18343.x.View ArticlePubMedGoogle Scholar
- Dawes C, Wood CCM: The contribution of the oral minor mucous gland secretions to the volume of whole saliva in man. Arch Oral Biol. 1973, 18: 337-342. 10.1016/0003-9969(73)90156-8.View ArticlePubMedGoogle Scholar
- Sonesson M: On minor salivary gland secretion in children, adolescents and adults. Swed Dent J Suppl. 2011, 215: 9-64.PubMedGoogle Scholar
- Mandel ID: Sialochemistry in diseases and clinical situations affecting salivary glands. Crit Rev Clin Lab Sci. 1980, 12: 321-366. 10.3109/10408368009108733.View ArticlePubMedGoogle Scholar
- Colella G, Cannavale R, Vicidomini A, Itro A: Salivary gland biopsy: a comprehensive review of techniques and related complications. Rheumatology. 2010, 49: 2117-2121. 10.1093/rheumatology/keq225.View ArticlePubMedGoogle Scholar
- Jabs DA, Enger C, Prendergast RA: Murine models of Sjogren’s syndrome. Evolution of the lacrimal gland inflammatory lesions. Invest Ophthalmol Vis Sci. 1991, 32: 371-380.PubMedGoogle Scholar
- Hunger RE, Carnaud C, Vogt I, Mueller C: Male gonadal environment paradoxically promotes dacryoadenitis in nonobese diabetic mice. J Clin Invest. 1998, 101: 1300-1309. 10.1172/JCI1230.View ArticlePubMedPubMed CentralGoogle Scholar
- Hann LE, Kelleher RS, Sullivan DA: Influence of culture conditions on the androgen control of secretory component production by acinar cells from the rat lacrimal gland. Invest Ophthalmol Vis Sci. 1991, 32: 2610-2621.PubMedGoogle Scholar
- Toda I, Sullivan BD, Rocha EM, Da Silveira LA, Wickham LA, Sullivan DA: Impact of gender on exocrine gland inflammation in mouse models of Sjögren’s syndrome. Exp Eye Res. 1999, 69: 355-366. 10.1006/exer.1999.0715.View ArticlePubMedGoogle Scholar
- Nguyen CQ, Peck AB: Unraveling the pathophysiology of Sjogren syndrome- associated dry eye disease. Ocul Surf. 2009, 7: 11-27. 10.1016/S1542-0124(12)70289-6.View ArticlePubMedPubMed CentralGoogle Scholar
- McGuirt WF, Whang C, Moreland W: The role of parotid biopsy in the diagnosis of pediatric Sjogren syndrome. Arch Otolaryngol Head Neck Surg. 2002, 128: 1279-1281. 10.1001/archotol.128.11.1279.View ArticlePubMedGoogle Scholar
- Pijpe J, Kalk WW, van der Wal JE, et al: Parotid gland biopsy compared with labial biopsy in the diagnosis of patients with primary Sjogren’s syndrome. Rheumatology. 2007, 46: 335-341.View ArticlePubMedGoogle Scholar
- Adam P, Haroun A, Billet J, Mercier J: Biopsy of the salivary glands. The importance and technic of biopsy of the sublingual gland on its anterio-lateral side. Rev Stomatol Chir Maxillofac. 1992, 93: 337-340.PubMedGoogle Scholar
- Pennec YL, Leroy JP, Jouquan J, Lelong A, Katsikis P, Youinou P: Comparison of labial and sublingual salivary gland biopsies in the diagnosis of Sjogren’s syndrome. Ann Rheum Dis. 1990, 49: 37-39. 10.1136/ard.49.1.37.View ArticlePubMedPubMed CentralGoogle Scholar
- Ohno K, Hattori T, Kagami H, Ueda M: Effects of preceding sialadenitis on the development of autoimmunity against salivary gland. Oral Dis. 2007, 13: 158-162. 10.1111/j.1601-0825.2005.01219.x.View ArticlePubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1472-6831/13/51/prepub
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.